Biopharmaceutical News and Research

RSS
Solutions to royalty stacking issues a top priority in pharmaceutical and biotechnology sectors

Solutions to royalty stacking issues a top priority in pharmaceutical and biotechnology sectors

Monoclonal antibody therapeutics to fill vacuum left by ineffective conventional therapies

Monoclonal antibody therapeutics to fill vacuum left by ineffective conventional therapies

Major European research initiative in the genetics of drug addiction

Major European research initiative in the genetics of drug addiction

Biopharmaceutical market generated revenues of USD 45.0 billion in 2004

Biopharmaceutical market generated revenues of USD 45.0 billion in 2004

Potential new therapies for cancer and bleeding disorders

Potential new therapies for cancer and bleeding disorders

Genaissance patent for novel methods to correlate genetics with drug safety and efficacy

Genaissance patent for novel methods to correlate genetics with drug safety and efficacy

Manufacturers in the European active pharmaceutical ingredients market are struggling to overcome a variety of challenges

Manufacturers in the European active pharmaceutical ingredients market are struggling to overcome a variety of challenges

New software for the investigation of cancer

New software for the investigation of cancer

Chiron responds to FDA announcement

Chiron responds to FDA announcement

Flu vaccine shortage highlights need to accelerate the approval of affordable generic biopharmaceuticals and vaccines

Flu vaccine shortage highlights need to accelerate the approval of affordable generic biopharmaceuticals and vaccines

University of Arizona spin-off investigates DNA damage to human skin

University of Arizona spin-off investigates DNA damage to human skin

ChemGenex discovers five new depression genes

ChemGenex discovers five new depression genes

RNAi enlisted in hunt for prawn vaccines

RNAi enlisted in hunt for prawn vaccines

Phase I clinical trial of new drug for severe asthma

Phase I clinical trial of new drug for severe asthma

Advances in gene silencing on the agenda

Advances in gene silencing on the agenda

MGI PHARMA acquires Aesgen for $32 million

MGI PHARMA acquires Aesgen for $32 million

Kiwis reverse heart disease in diabetics

Kiwis reverse heart disease in diabetics

Development of plant-derived topical medications to prevent HIV/AIDS and other STD's

Development of plant-derived topical medications to prevent HIV/AIDS and other STD's

IBM and Cellomics offer new solution to accelerate cell-based drug discovery

IBM and Cellomics offer new solution to accelerate cell-based drug discovery

Patent pending botanical extract, V38-AMF-1, completely inhibits bird flu (H5N1) and Fujian Flu

Patent pending botanical extract, V38-AMF-1, completely inhibits bird flu (H5N1) and Fujian Flu